Status:
COMPLETED
Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Neoadjuvant Chemoradiotherapy
Rectal Tumor
Eligibility:
All Genders
18-90 years
Brief Summary
Neoadjuvant radio-chemotherapy (NRCT) represents a milestone in the treatment of selected rectal tumours. Ideal time interval between the end of NRCT and surgery is still debated; a 6-8 weeks time int...
Detailed Description
Neoadjuvant radio-chemotherapy (NRCT) represents a milestone in the treatment of selected rectal adenocarcinoma. Even though a 6-8 weeks' time interval after the end of NRCT and surgery is considered ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- patients with rectal adenocarcinoma who underwent to resection after combined NRCT at University Campus Bio-Medico di Roma from January 2005 to March 2015.
- To evaluate the anastomotic dehiscence were excluded patients undergone to Abdomino-perineal resection (APR) and 4 patients for whom data were not available.
Exclusion
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2017
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT04013347
Start Date
January 1 2005
End Date
March 21 2017
Last Update
July 9 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.